Clinical trial
Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
NCT00000430 · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH · Terminated
Key facts
| NCT number | NCT00000430 |
|---|---|
| Title | Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis |
| Official title | Clinical Trial of Continuous Low-Dose Hormone Replacement Therapy Combined With Alendronate in Postmenopausal Women With Low Bone Density |
| Lead sponsor | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteopenia, Osteoporosis |
| Intervention type | Drug |
| Interventions | Alendronate, Estrogen/progestin therapy |
| Enrollment | 240 |
| Start date | Oct 1, 1999 |
| Completion | Sep 1, 2004 |
| First posted | Jan 19, 2000 |
| Last update posted | Jan 4, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: